Yesterday, we commented on top 10 medical innovations reported at the Cleveland Clinic Innovation Summit. At the summit, Boston Scientific CEO Jim Tobin’s presentation underscored the other point we made recently, that acquisition is a routine part of medtech’s drive for innovation. Boston Scientific has some $2 billion on hand and is looking for companies [...]
bookmark to
